New weapon tested in battle against advanced ovarian cancer
Disease control
Ongoing
This study is testing whether adding a new experimental drug called IMNN-001 to standard chemotherapy before surgery can better control advanced ovarian, fallopian tube, or primary peritoneal cancer. The drug is designed to stimulate the immune system and is delivered directly in…
Phase: PHASE1, PHASE2 • Sponsor: Imunon • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC